logo
Plus   Neg
Share
Email

Cannalogue Seeks To Conduct Clinical Trial For COVID-19 Using Medical Cannabis

Canadian cannabis healthcare technology company Cannalogue said it has submitted an application to Health Canada to conduct a clinical trial with medical cannabis for COVID-19, the disease caused by the novel coronavirus.

Toronto-based Cannalogue added that if approved by Health Canada, it will enroll patients into the research study to determine if medical cannabis can reduce the symptoms caused by COVID-19 or any mutant strains of the coronavirus.

The company has launched a website for volunteers to apply in the event the clinical trial is approved by Health Canada. Cannalogue had received Health Canada's first direct-to-sales licence for medical cannabis.

The specialists at Cannalogue believe the active medical ingredients from the cannabis plant could potentially boost the immune system and help reduce the severity of symptoms caused by the coronavirus.

"We are not suggesting with the current knowledge of medical cannabis that it is a prevention, treatment or cure for COVID-19 or coronaviruses. However, plant cannabinoids have naturally occurring immunomodulatory properties that absolutely require expedited investigation given the current global COVID-19 pandemic," said Dr. Mohan Cooray, President and CEO of Cannalogue.

Cooray, who is also a specialist in Internal Medicine, Gastroenterology, and Hepatology, noted that cannabinoid receptors are naturally found on immune cells in the body.

If these cannabinoid receptors are stimulated before an infection, they may dampen the inflammatory response that follows, which is a key factor in the severity of symptoms observed in patients, Cooray added.

Cannabinoids are chemicals found in cannabis. The cannabis plant contains more than 110 cannabinoids and 120 terpenes.

The primary ingredient in marijuana is tetrahydrocannabinol or THC, a psychoactive compound that induces the "high" and hallucinogenic effect in the user. Cannabidiol or CBD is another compound in marijuana. But unlike THC, CBD does not cause a high and is often used for medicinal purposes.

Cannalogue said that in support of the medical cannabis sector and scientific research community, it will release an exclusive insider health report that reveals key medical insights on emerging therapeutic areas with respect to medical cannabis.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT